Core Laboratories (CLB) EPS (Basic) (2022 - 2026)

Core Laboratories' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.02 for Q1 2026.

• On a quarterly basis, EPS (Basic) fell 1207.88% year-over-year to -$0.02 in Q1 2026; TTM through Mar 2026 was $0.64, a 9.9% decrease from a year earlier, with the FY2025 full-year figure at $0.65, down 16.2% from the prior year.
• EPS (Basic) fell to -$0.02 in Q1 2026 per CLB's latest filing, from $0.11 in the prior quarter.
• Across five years, EPS (Basic) topped out at $0.49 in Q2 2023 and bottomed at -$0.18 in Q4 2023.
• The 5-year median for EPS (Basic) is $0.18 (2022), against an average of $0.16.
• Across the five-year window, EPS (Basic) jumped 239.06% in 2024 and sank 1207.88% in 2026, its largest moves.
• Year by year, EPS (Basic) stood at $0.21 in 2022, then plunged by 189.04% to -$0.18 in 2023, then surged by 239.06% to $0.26 in 2024, then slumped by 56.8% to $0.11 in 2025, then slumped by 114.79% to -$0.02 in 2026.
• Per Business Quant, the three latest CLB EPS (Basic) figures stand at -$0.02 (Q1 2026), $0.11 (Q4 2025), and $0.31 (Q3 2025).